146 related articles for article (PubMed ID: 8891480)
21. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL
J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222
[TBL] [Abstract][Full Text] [Related]
22. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
23. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
Kim HJ; Tinling SP; Chole RA
J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
[TBL] [Abstract][Full Text] [Related]
24. Localisation of basic fibroblast growth factor in cholesteatoma matrix: an immunochemical study.
Hamed MA; Sayed RH; Shiogama K; Eltaher MA; Suzuki K; Nakata S
J Laryngol Otol; 2019 Mar; 133(3):183-186. PubMed ID: 30808433
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
[TBL] [Abstract][Full Text] [Related]
26. Sustained extracellular signal-regulated kinase1/2 mitogen-activated protein kinase signalling is related to increased p21 expression in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2005 Feb; 125(2):134-40. PubMed ID: 15880942
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
Li H; Jiang P; Wang L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
[TBL] [Abstract][Full Text] [Related]
28. Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.
Caffier PP; Marzahn U; Franke A; Sudhoff H; Jovanovic S; Haisch A; Sedlmaier B
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1179-88. PubMed ID: 18253741
[TBL] [Abstract][Full Text] [Related]
29. Expression of annexin II in human middle ear cholesteatoma.
Kim TT; Chen CT; Huang CC
Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):324-8. PubMed ID: 9527111
[TBL] [Abstract][Full Text] [Related]
30. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
Yamamoto-Fukuda T; Akiyama N
Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor in middle ear cholesteatoma.
Fujioka O; Huang CC
Eur Arch Otorhinolaryngol; 1994; 251(4):199-204. PubMed ID: 7917251
[TBL] [Abstract][Full Text] [Related]
32. Signal transduction pathway in human middle ear cholesteatoma.
Myers EN; Park K; Chun Ym; Lee Dh; Hwang Sc
Otolaryngol Head Neck Surg; 1999 Jun; 120(6):899-904. PubMed ID: 10352447
[TBL] [Abstract][Full Text] [Related]
33. Survival signaling and terminal differentiation in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2007 Apr; 127(4):424-9. PubMed ID: 17453465
[TBL] [Abstract][Full Text] [Related]
34. Expression of female sex hormone receptors in human middle-ear cholesteatomas.
Raynov AM; Choung YH; Moon SK; Park K
J Laryngol Otol; 2005 Dec; 119(12):941-5. PubMed ID: 16354354
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
[TBL] [Abstract][Full Text] [Related]
37. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor.
Fukudome S; Wang C; Hamajima Y; Ye S; Zheng Y; Narita N; Sunaga H; Fujieda S; Hu X; Feng L; Lin J
JAMA Otolaryngol Head Neck Surg; 2013 Mar; 139(3):273-8. PubMed ID: 23657791
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor expression in middle ear cholesteatoma.
Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.
Zeng L; Xie L; Hu J; He C; Liu A; Lu X; Zhou W
Cell Cycle; 2024 Mar; 23(5):537-554. PubMed ID: 38662954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
